Quick Answer
Cigna Group reported Cash and Equivalents of $7.68 billion for fiscal year 2025.
Cigna Group Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $7.68B | +1.7% |
| 2024 | $7.55B | -3.5% |
| 2023 | $7.82B | +32.0% |
| 2022 | $5.92B | +16.6% |
| 2021 | $5.08B | -50.1% |
| 2020 | $10.18B | +120.4% |
| 2019 | $4.62B | +19.8% |
| 2018 | $3.85B | +29.7% |
| 2017 | $2.97B | -6.7% |
| 2016 | $3.19B | +61.8% |
| 2015 | $1.97B | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.03B | +2.3% | +39.2% |
| June 30, 2025 | $4.33B | -36.2% | -48.1% |
| March 31, 2025 | $8.33B | -1.2% | +10.4% |
| December 31, 2024 | $7.55B | -3.5% | +28.2% |
| September 30, 2024 | $5.89B | -30.7% | -13.3% |
| June 30, 2024 | $6.79B | -29.2% | -19.6% |
| March 31, 2024 | $8.44B | +6.4% | +7.9% |
| December 31, 2023 | $7.82B | +32.0% | -7.9% |
- Cigna Group showed an increase of +1.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2015–2025 period, Cigna Group’s cash and equivalents has grown by 290.0% (from $1.97 billion to $7.68 billion).
- The most recent figure is from Cigna Group’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: